Keri S. Kim
Clinical Assistant Professor/Clinical Pharmacist, College of Pharmacy - Pharmacy Practice
Contact
Office Phone:
Email:
Related Sites:
About
Research Interests:
Thrombosis and hemostasis
Teaching and Supervision
PDAT 3:Renal, Electro, Nutrtn (PHAR 503), 8/25/2025 – 12/5/2025
PDAT 505 Principles of Drug Action and Therapeutics 5 (PHAR 505), 4/23/2025 – 4/23/2025
PMPR 376 Applied Research Methods and Skill Development (PMPR 430), 3/3/2025 – 3/3/2025
PHR 5617 Pharmacotherapeutics I for University of Malta: Potassium Homeostasis, Magnesium Homeostasis Lecture and Recitation (PHR 5617), 2/27/2025 – 2/27/2025
PMPR 430 Critical Care I (PMPR 430), 2/24/2025 – 2/24/2025
PDAT 510 Principles of Drug Action and Therapeutics 10: Advanced Disease Management (PDAT 510), 2/24/2025 – 3/14/2025
PMPR 390 Independent Study: Projects: Introduction to Medication History and Reconciliation (PMPR 390), 1/13/2025 – 5/3/2024
PMPR 380 Special Project: Introduction to Research, Data Collection and Interpretation (CRN 12959) (PMPR 380), 1/13/2025 – 5/2/2025
PDAT 3:Renal, Electro, Nutrtn (PHAR 503), 10/24/2024 – 11/11/2024
Selected Grants
COVID19 Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP), Global Coalition for Adaptive Research., 6/16/2021 - 5/3/2022, Obligated Amount: $223052; Anticipated Amount: $223052
COVID19 Novel Experimental COVID Therapies Affecting Host Response (NECTAR) ACTIV 4d RAAS, Vanderbilt University Medical Center., 3/1/2021 - 8/1/2022, Obligated Amount: $270316; Anticipated Amount: $270316
Convalescent Plasma To Limit Coronavirus Associated Complications: A Randomized Blinded Phase 2 Study Comparing The Efficacy And Safety Of Anti-Sars-Cov-2 Plasma To Placebo In Covid-19 Hospitalized Pa, New York University School of Medicine., 2/15/2021 - 6/30/2022, Obligated Amount: $22501; Anticipated Amount: $22501
COVID19 CTA - ACTIV-IV Post-Hospital Platform, University of Pittsburgh., 12/1/2020 - 11/30/2022, Obligated Amount: $1734537; Anticipated Amount: $1883768
COVID19 CTA: ACTIV-IV Post Hospital Platform, University of Pittsburgh., 12/1/2020 - 11/30/2022, Obligated Amount: $4277904; Anticipated Amount: $4277904
Thrombotic Complications in COVID-19 Pneumonia Compared to Bacterial Pneumonia and Viral Pneumonia, University of Illinois Health., 11/2/2020 - 12/31/2021, No Obligated Amount Set; No Anticipated Amount Set
COVID19 A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitals Adults with COVID-19, New York University School of Medicine., 9/25/2020 - 5/31/2023, Obligated Amount: $851000; Anticipated Amount: $851000
CTA: COVID19 ACTIV-IV Inpatient Platform (ACTIV4a), University of Pittsburgh., 7/1/2020 - 5/31/2023, Obligated Amount: $1273013; Anticipated Amount: $1273013
Comparison of percent adjusted vs. predefined incremental argatroban dosing nomograms: more frequent monitoring does not improve time to therapeutic anticoagulation, University of Illinois Health., 7/1/2019 - 8/31/2021, No Obligated Amount Set; No Anticipated Amount Set
Selected Publications
Kim, Keri S, Fitzpatrick, Mya, Patel, Ruchi, Gandhi, Nishita, Garofalo, John, Mucksavage, Jeffrey J. (2025). 96 The Effect of Individualized Intravenous Heparin Dosing on Activated Partial Thromboplastin Time Values in Neurocritical Care Patients. Research and Practice in Thrombosis and Haemostasis, 9, 102777. doi:10.1016/j.rpth.2025.102777.
Kosiborod, Mikhail N, Windsor, Sheryl L, Vardeny, Orly, Berger, Jeffrey S, Reynolds, Harmony R, Boumakis, Stavroula, Althouse, Andrew D, Solomon, Scott D, Bhatt, Ankeet S, Peikert, Alexander, Luther, James F, Leifer, Eric S, Kindzelski, Andrei L, Cushman, Mary, Gong, Michelle Ng, Kornblith, Lucy Z, Khatri, Pooja, Kim, Keri S, Kreuziger, Lisa Baumann, Javaheri, Ali, Carpio, Carlos, Wahid, Lana, Moreno, Jose Lopez-Sendon, Alonso, Alvaro, Ho, Minh Quang, Lopez-Sendon, Jose, Lopes, Renato D, Curtis, Jeffrey L, Kirwan, Bridget-Anne, Geraci, Mark W, Neal, Matthew D, Hochman, Judith S, Caramori, PR Avancini, Hernandes, M Esteves, Babudieri, S, Contoli, M, Fernando, M, Juanatey, Gonzalez, Estellez, F Ibañez, Mateos, E, Tidswell, M, Akala, O, Pursley, M, Jathavedam, A, Markley, J, Gelman, M, Ajani, Z, Mackay, F, Kunisaki, K, Martin, K, Exline, M, Huggins, J, Nicholson, L, Lim, G, Aboudara, M, Sherwin, R, Torbati, S, Wilson, J, Latorre, JG, Busch, J, Albertson, T, Matthay, M, Gandotra, S, Joseph, B, Hudock, K, Iovine, N, Quigley, J, Hyzy, R, Kutcher, M, Huang, D, Pandey, A, Sheehan, J, Solankhi, N, Huang, D, Rodriguez, W, Shah, B, Khanna, A, Bochicchio, G, McCarthy, M, Pan, S, Balasubraman, P. (2024). Effect of sodium–glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial. The Lancet Diabetes & Endocrinology, 12, (10), 725-734. doi:10.1016/s2213-8587(24)00218-3.
Kim, Keri S, Polizzotto, Leonard, Suarez, Jose I, Olson, DaiWai M, Hemphill, J Claude, Mainali, Shraddha. (2024). An Update on Curing Coma Campaign. Seminars in Neurology, 44, (03), 389-397. doi:10.1055/s-0044-1785478.
Muehlschlegel, Susanne, Rajajee, Venkatakrishna, Wartenberg, Katja E, Alexander, Sheila A, Busl, Katharina M, Creutzfeldt, Claire J, Fontaine, Gabriel V, Hocker, Sara E, Hwang, David Y, Kim, Keri S, Madzar, Dominik, Mahanes, Dea, Mainali, Shraddha, Meixensberger, Juergen, Sakowitz, Oliver W, Varelas, Panayiotis N, Weimar, Christian, Westermaier, Thomas. (2024). Guidelines for Neuroprognostication in Critically Ill Adults with Moderate–Severe Traumatic Brain Injury. Neurocritical Care, 40, (2), 448-476. doi:10.1007/s12028-023-01902-2.
Mahanes, Dea, Muehlschlegel, Susanne, Wartenberg, Katja E, Rajajee, Venkatakrishna, Alexander, Sheila A, Busl, Katharina M, Creutzfeldt, Claire J, Fontaine, Gabriel V, Hocker, Sara E, Hwang, David Y, Kim, Keri S, Madzar, Dominik, Mainali, Shraddha, Meixensberger, Juergen, Varelas, Panayiotis N, Weimar, Christian, Westermaier, Thomas, Sakowitz, Oliver W. (2024). Guidelines for neuroprognostication in adults with traumatic spinal cord injury. Neurocritical Care, 40, (2), 415-437. doi:10.1007/s12028-023-01845-8.
Hwang, David Y, Kim, Keri S, Muehlschlegel, Susanne, Wartenberg, Katja E, Rajajee, Venkatakrishna, Alexander, Sheila A, Busl, Katharina M, Creutzfeldt, Claire J, Fontaine, Gabriel V, Hocker, Sara E, Madzar, Dominik, Mahanes, Dea, Mainali, Shraddha, Sakowitz, Oliver W, Varelas, Panayiotis N, Weimar, Christian, Westermaier, Thomas, Meixensberger, Jürgen. (2024). Guidelines for Neuroprognostication in Critically Ill Adults with Intracerebral Hemorrhage. Neurocritical Care, 40, (2), 395-414. doi:10.1007/s12028-023-01854-7.
Godoy, Lucas C, Neal, Matthew D, Goligher, Ewan C, Cushman, Mary, Houston, Brett L, Bradbury, Charlotte A, McQuilten, Zoe K, Tritschler, Tobias, Kahn, Susan R, Berry, Lindsay R, Lorenzi, Elizabeth, Jensen, Tom, Higgins, Alisa M, Kornblith, Lucy Z, Berger, Jeffrey S, Gong, Michelle N, Paul, Jonathan D, Castellucci, Lana A, Le Gal, Grégoire, Lother, Sylvain A, Rosenson, Robert S, Derde, Lennie PG, Kumar, Anand, McVerry, Bryan J, Nicolau, Jose C, Leifer, Eric, Escobedo, Jorge, Huang, David T, Reynolds, Harmony R, Carrier, Marc, Kim, Keri S, Hunt, Beverley J, Slutsky, Arthur S, Turgeon, Alexis F, Webb, Steven A, McArthur, Colin J, Farkouh, Michael E, Hochman, Judith S, Zarychanski, Ryan, Lawler, Patrick R. (2024). Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19. JACC Advances, 3, (3), 100780. doi:10.1016/j.jacadv.2023.100780.
Busl, Katharina M, Fried, Herbert, Muehlschlegel, Susanne, Wartenberg, Katja E, Rajajee, Venkatakrishna, Alexander, Sheila A, Creutzfeldt, Claire J, Fontaine, Gabriel V, Hocker, Sara E, Hwang, David Y, Kim, Keri S, Madzar, Dominik, Mahanes, Dea, Mainali, Shraddha, Meixensberger, Juergen, Sakowitz, Oliver W, Varelas, Panayiotis N, Westermaier, Thomas, Weimar, Christian. (2023). Author Correction: Guidelines for Neuroprognostication in Adults with Guillain–Barré Syndrome. Neurocritical Care, 39, (3), 752-752. doi:10.1007/s12028-023-01830-1.
Goldberg, Rachel, Ye, William, Johns, Kevin, Mucksavage, Jeffrey J, Dhandapani, Shvetha, Quigley, John G, Shapiro, Nancy L, Benken, Scott T, Wenzler, Eric, Kim, Keri S. (2023). Comparison of thrombotic and clinical outcomes in SARS-CoV-2-pneumonia versus other viral pneumonia in an urban academic medical center. Heart & Lung, 61, 153-157. doi:10.1016/j.hrtlng.2023.05.005.
Professional Leadership
Neurocritical Care Society (NCS) Guidelines Committee, Neurocritical Care Society (NCS), 10/1/2023 - 10/31/2025
Curing Coma Campaign (Acknowledgement), 3/31/2023 - 3/31/2023
Curing Coma Campaign (Acknowledgement), Neurocritical Care Society, 3/28/2023 - 3/28/2023
Curing Coma Campaign (Acknowledgement), Neurocritical Care Society, 7/8/2021 - 7/8/2021
Neurocritical Care Society (NCS) Guidelines Committee, Neurocritical Care Society (NCS), 10/1/2020 - 9/30/2023
Neurocritical Care Society Curing Coma Campaign Executive Committee, Neurocritical Care Society (NCS), 1/1/2019 - 3/31/2025
Neurocritical Care Society (NCS) Research Operations Sub-Committee, Neurocritical Care Society (NCS), 10/1/2017 - 9/30/2021
Notable Honors
2025, 2024 Investigator of the Year Award, University of Illinois Retzky College of Pharmacy
2025, Honor, Neurocritical Care Society Curing Coma Campaign Executive Committee, Neurocritical Care Society
2022, 2022 Presidential Citation Award, Neurocritical Care Society
2022, 2022 Fellow of Neurocritical Care Society (FNCS), Neurocritical Care Society
2020, 2020 Presidential Citation Award, Neurocritical Care Society
Education
Degrees:
Master of Science in Clinical and Translation Science (MS CTS), University of Illinois at Chicago, United States, 2010
Doctor of Pharmacy, University of Illinois at Chicago, United States, 2003
Pre-Pharmacy Curriculum, University of Illinois at Chicago, United States, 1999
Postgraduate Training:
Critical Care Specialty Resident, Virginia Commonwealth University, United States, 2005
Pharmacy Practice Resident, University of Illinois at Chicago College of Pharmacy, United States, 2004
Licensures and Certifications
Board Certified Pharmacotherapy Specialist, American College of Clinical Pharmacy, 11/2005 - Present
Teaching Certificate Program, University of Illinois at Chicago, 7/2004 - Present
Advanced Cardiac Life Support Provider, American Heart Association, 7/2003 - Present
Basic Life Support Provider, American Heart Association, 1/2003 - Present
Pharmacists-Based Immunization Delivery, American Pharmacists Association Foundation, 1/2003 - Present
Pharmacist, Illinois Board of Pharmacy, 8/2003 - Present
Pharmacist, Virginia Board of Pharmacy, 8/2004 - 12/2005
Pharmacist, Texas Board of Pharmacy, 3/2019 - Present